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Abstract Magnetic hyperthermia is a fast emerging, non-invasive cancer treatment method which is used synergistically
with the existing cancer therapeutics. We have attempted to address the current challenges in clinical magnetic hyper-
thermia-improved biocompatibility and enhanced heating characteristics, through a single combinatorial approach. Both
superparamagnetic iron oxide nanoparticles (SPIONs) of size 10 nm and ferrimagnetic iron oxide nanoparticles (FIONs) of
size 30 nm were synthesized by thermal decomposition method for comparison studies. Two different surface modifying
agents, viz, Cetyl Trimethyl Ammonium Bromide and 3-Aminopropyltrimethoxysilane, were used to conjugate Bovine
Serum Albumin (BSA) over the iron oxide nanoparticles via two different methods—surface charge adsorption and
covalent amide bonding, respectively. The preliminary haemolysis and cell viability experiments show that BSA conju-
gation mitigates the haemolytic effect of the iron oxide nanoparticles on erythrocytes and is non-cytotoxic to the healthy
Baby Hamster Kidney cells. It was observed from the results that due to better colloidal stability, the SAR value of the
BSA-iron oxide nanoparticles is higher than the iron oxide nanoparticles without BSA, irrespective of the size of the iron
oxide nanoparticles and method of conjugation. The BSA-FIONs seem to show improved biocompatibility, as the hae-
molytic index is less than 2 % and cell viability is up to 120 %, when normalized with the control. The SAR value of BSA-
FIONs is 2300 W g-1 when compared to 1700 W g-1 of FIONs without BSA conjugation. Thus, we report here that BSA
conjugation over FIONs (with a high saturation magnetization of 87 emu g-1) provide a single combinatorial approach to
improve the biocompatibility and enhance the SAR value for magnetic hyperthermia, thus addressing both the current
challenges of the same.
Keywords Magnetic hyperthermia  Ferrimagnetic iron oxide nanoparticles  Bovine serum albumin  Haemolysis  Cell
viability  Specific absorption rate
1 Introduction
Cancer is a global killer disease. All the existing cancer
treatment strategies like chemotherapy, radiotherapy, and
hyperthermia techniques [1, 2] aim to alleviate cancer.
Magnetic hyperthermia is a non-invasive technique which
is better than the other hyperthermia techniques as it
ensures targeted heating of the tumor tissue [3, 4]. Mag-
netic nanoparticles are a pre-requisite for an efficient
magnetic hyperthermia system. Iron oxide nanoparticles
with suitable surface modification and functionalization
have a plethora of applications in magnetic resonance
imaging (MRI), targeted drug delivery, cell separation, cell
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sorting, especially in magnetic hyperthermia [5–7], etc. In
magnetic hyperthermia technique, iron oxide nanoparticles
are injected into the tumor site and are subjected to an
external alternating current (AC) magnetic field which
raises the temperature of the tumor site up to 42–46 C.
This causes tumor cell death due to necrosis, incase of high
dose of temperature–time [8–10] or apoptosis due to mild
exposure and cell sensitization to chemotherapy and
radiotherapy incase sublethal dose of temperature–time
[11, 12]. Since iron oxide nanoparticles are injected into
the biological system to bring about the temperature raise,
a system with a very good biocompatibility and heating
efficacy is the fundamental requirement for an efficient
magnetic hyperthermia system. Thus, the current chal-
lenges to be addressed in the field of clinical magnetic
hyperthermia are improved biocompatibility and enhanced
heating characteristics.
Extensive research has been done to improve the bio-
compatibility and blood circulation of iron oxide
nanoparticles by numerous surface modification and func-
tionalization strategies for various biomedical applications
[13–18]. Similarly, various attempts have been made to
enhance the specific absorption rate (SAR) value of the
iron oxide nanoparticles by controlling the aggregation,
saturation magnetization, anisotropy, etc. [19–22]. The size
and shape of the iron oxide nanoparticles can also be
controlled in order to improve the SAR value and thereby
enhance the heating characteristics [23]. Achieving both
biocompatibility and improved heating efficacy without
compromising on either factor poses a huge challenge in
the research of clinical magnetic hyperthermia. This paper
attempts to address both the pressing challenges by a single
combinatorial approach.
Biocompatible iron oxide nanoparticles for magnetic
hyperthermia using polymers like poly ethylene glycol
(PEG), poly vinyl pyrolidone (PVP), poly ethyleneimine
(PEI), biomacromolecules like proteins, aptamers, DNA,
and surfactants like CTAB are well reported [24–26].
Combinatorial approach to simultaneously improve the
biocompatibility and SAR value using noble metal like
Platinum-coated iron oxide core–shell nanoparticles are
also reported [27, 28]. Chemical surface modifying agents
render good hydrophilicity and stability to the iron oxide
nanoparticles. But they are cytotoxic when used beyond the
optimum threshold level [29–31]. Therefore, biomacro-
molecules like DNA and proteins are preferred surface
functionalization agents. For our work, we have chosen
bovine serum albumin (BSA) as the biocompatibility agent.
Albumin is a versatile protein which forms almost 55 % of
blood plasma protein content and helps maintain the pH
and osmotic pressure of blood [32, 33]. Thus, BSA con-
jugation improves the stealth characteristics of iron oxide
nanoparticles and hence prolongs the blood circulation
time [34, 35]. BSA is also reported to raise the temperature
of a nanoparticle system under an applied AC magnetic
field by the formation of isotropic clusters [36]. Previous
reports of Human Serum Albumin (HSA)-conjugated
superparamagnetic iron oxide nanoparticles (SPIONs) by
Keshavarz et al. and BSA-conjugated SPIONs by Samanta
et al. [37] also show that albumin conjugation improves the
colloidal stability and thereby the SAR value for magnetic
hyperthermia. In these reports, SPIONs were synthesized
by inorganic co-precipitation method and albumin was
conjugated by physical adsorption method. Thus, we have
chosen BSA as our single preferred candidate for both
improved biocompatibility and enhanced heating effi-
ciency. Moreover ferrimagnetic iron oxide nanoparticles
(FIONs) have higher saturation magnetization and hence
better SAR value than SPIONs [38, 39]. The unique heat
enhancement property of BSA adds further value to heating
efficiency of FIONs. Therefore, BSA and FIONs are the
candidates of interest for the single combinatorial approach
to address the challenges in magnetic hyperthermia.
We have fabricated BSA-conjugated SPIONs of size
10 nm and FIONs of size 30 nm. The iron oxide
nanoparticles were synthesized by thermal decomposition
method using organic precursors [40, 41]. This is the
highly preferred method for synthesizing iron oxide
nanoparticles of uniform shape, size, and monodispersity
when compared to the inorganic synthesis protocols [42–
44]. Though inorganic synthesis protocols can generate
hydrophilic iron oxide nanoparticles, the thermal decom-
position method produces better quality hydrophobic iron
oxide nanoparticles. The challenges in finding a suit-
able surface modifying agent to overcome the hydropho-
bicity of the as-synthesized iron oxide nanoparticles were
met out. Two surface modifying agents, viz, Cetyl Tri-
methyl Ammonium Bromide (CTAB) and 3-aminopropy-
ltrimethoxysilane (APTMS), were used to render
preliminary hydrophilicity to the as-synthesized
hydrophobic iron oxide nanoparticles and also to facilitate
the conjugation of BSA by two different approaches—
physical adsorption by surface charge interaction (CTAB-
iron oxide nanoparticles) and strong covalent amide
bonding by 1-ethyl-3-(-3-dimethylaminopropyl) carbodi-
imide hydrochloride (EDC) method (APTMS-iron oxide
nanoparticles). The haemolytic and cell viability studies
show that the biocompatibility of the BSA-iron oxide
nanoparticles is improved when compared to the hydro-
philic iron oxide nanoparticles without BSA. The SAR
value of BSA-iron oxide nanoparticles is also significantly
enhanced, irrespective of the size of the iron oxide
nanoparticle and method of BSA conjugation.
Our results show that BSA-conjugated FIONs show
better biocompatibility and heating characteristics when
compared to the BSA-conjugated SPIONs and hydrophilic
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SPIONs/FIONs without BSA conjugation. It is also evident
from our results that BSA conjugation over iron oxide
nanoparticles through covalent amide bond formation is
better than physical adsorption in improving the biocom-
patibility and SAR value. To the best of our best knowl-
edge, there are no previous attempts to fabricate a single
combinatorial system of BSA-FIONs to address the two
main challenges in clinical magnetic hyperthermia-bio-
compatibility and high heating efficiency.
2 Materials and Methods
2.1 Synthesis of Iron Oxide Nanoparticles
The iron oxide nanoparticles were chemically synthesized
by the thermal decomposition method as described else-
where [45, 46]. The chemical composition and physical
parameters were modified as per the requirements. Briefly,
iron(III) acetylacetonate (Sigma Aldrich) was added to
oleic acid (Sigma Aldrich) and benzyl ether (Sigma
Aldrich) in required composition and heated under nitrogen
purging to 110 C in order to remove moisture. The tem-
perature was later increased to 160 C, to initiate nucle-
ation. The reaction was maintained at 280 C with reflux to
promote growth of the iron oxide nanoparticles. The size of
the iron oxide nanoparticles depends on the duration of the
reaction which is maintained at 280 C.
We have synthesized SPIONs of size 10 nm and FIONs
of size 30 nm. The as-synthesized iron oxide nanoparticles
were characterized for their shape and size using Trans-
mission Electron Microscope (TEM, JEOL 100CX). The
magnetization properties of the two different sizes—10 nm
SPIONs and 30 nm FIONs—were investigated using
Vibrating Sample Magnetometer (VSM, Lake Shore Model
7407) and Superconducting Quantum Interference Device
(SQUID, QuantumDesign). The size, crystallinity, and
purity of the sample were studied using X-ray diffrac-
tometer (XRD, Bruker D8 Advanced Diffractometer Sys-
tem with Cu Ka (1.5418 A˚) source).
2.2 Surface Modification of Iron Oxide
Nanoparticles
2.2.1 Conversion to Hydrophilic Phase
The as-synthesized iron oxide nanoparticles were
hydrophobic in nature due to the oleic acid capping. The iron
oxide nanoparticles have to be converted to hydrophilic
phase so as to use it for in vitro and in vivo applications.
2.2.1.1 Cationic Capping Using CTAB The strategy of
phase transfer using additional hydrophilic molecular layer
over the original ligand (oleic acid) of iron oxide
nanoparticles was used in this approach. CTAB is a quar-
ternary salt whose hydrocarbon chains adsorb onto the
oleic moiety of the iron oxide nanoparticles, allowing the
cationic ammonium moiety to face out into the solution,
making the iron oxide nanoparticles hydrophilic [47].
Briefly, 0.1 M of CTAB was added to 10 mg iron oxide
nanoparticles. The mixture was vortexed and heated to
80 C. The reaction was stopped after 3 h, and the mixture
was washed thrice with ethanol and distilled water. The
product was well dispersed and stored in de-ionised water.
2.2.1.2 Ligand Exchange by APTMS In the ligand
exchange strategy, the hydrophilic ligand with more
affinity towards the inorganic iron core replaces the origi-
nal hydrophobic ligand capping the iron oxide nanoparti-
cles, thus rendering hydrophilicity [48].
In our experiments, the silane group of APTMS was
exchanged for oleic moiety on the iron oxide nanoparticles.
Briefly, 1 mg of iron oxide nanoparticles was dispersed in
10 mL toluene. To the dispersion, 90 lL of APTMS was
added and vortexed thoroughly. The mixture was kept in
the shaker at room temperature for 72 h for the ligand
exchange reaction to take place. The reaction mixture was
washed with ethanol and later with distilled water. The
product was found to be well dispersed in water.
The hydrodynamic radius and thereby the stability of the
hydrophilic iron oxide nanoparticles over a period of time
were studied using Dynamic Light Scattering technique
(DLS, Malvern Zetasizer Nano-ZS). The coating of surface
modified agents over the oleic acid-capped iron oxide
nanoparticles was confirmed by Fourier Transform Infra
Red spectroscopy (FTIR, Varian 3100).
2.2.2 Conjugation of BSA
Conjugation of biomacromolecules like proteins on to the
hydrophilic iron oxide nanoparticles, improves the col-
loidal stability and specificity of the system [49–51].
Generally, the inner side of a protein is hydrophobic while
it exposes its hydrophilic amino acid side into the solution.
This attribute makes it favourable for researchers to make
biocompatible protein-nanoparticle systems [52]. In our
experiment, BSA (Sigma Aldrich) was conjugated over the
hydrophilic iron oxide nanoparticles in order to render
improved biocompatibility and blood circulation.
2.2.2.1 Physical Adsorption using CTAB In this method
of physical adsorption, the cationic CTAB-iron oxide
nanoparticles were incubated with anionic BSA. BSA is
anionic in nature due to the carboxylate moiety in the
amino acids. It can be physically adsorbed on to the
cationic CTAB-iron oxide nanoparticles by surface charge
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interaction. 2 mg mL-1 of BSA in 1X Phosphate Buffer
Saline (PBS) buffer was added to the hydrophilic CTAB-
iron oxide nanoparticles and was left in shaker overnight
and washed thoroughly with distilled water.
2.2.2.2 Covalent Amide Bond Formation using APTMS
The APTMS-capped iron oxide nanoparticles have exposed
amino groups. The carboxylic groups on the BSA can be
activated by the EDC method [53]. A strong amide bond
was formed between the carboxylic group of BSA and
amino group of APTMS-capped iron oxide nanoparticles.
Briefly, 26 mM EDC and 10 mM NHS were prepared in
MES (2-(N-morpholino) ethane sulfonic acid) buffer.
200 lL of EDC/NHS/MES mixture was added to 1 mL
BSA (2 mg mL-1) to activate the carboxylic group. 2 mL
of APTMS-iron oxide nanoparticles was dispersed in 1X
PBS (0.1 mg mL-1). The pH was maintained around
7.2–7.4. Both the solutions were then mixed and left in the
shaker overnight at room temperature. The reaction was
terminated and the product was washed.
The conjugation of BSA individually over the iron oxide
nanoparticles was confirmed using TEM. The hydrody-
namic radius and thereby the stability of the BSA-conju-
gated iron oxide nanoparticles over a period of time were
studied using Dynamic Light Scattering technique (DLS,
Malvern Zetasizer Nano-ZS). The BSA conjugation over
iron oxide nanoparticles was also confirmed using Ultra
Violet-Visible Spectroscopy (UV–Vis, Shimadzu UV-
1601) and Zetapotential (DLS, Malvern Zetasizer Nano-
ZS) studies. Figure 1a, b gives simple schematic repre-
sentation of the mechanisms behind BSA conjugation using
CTAB and APTMS, respectively.
2.3 Improvement of Biocompatibility
2.3.1 Blood Aggregation and Haemolytic Studies
Erythrocytes were collected by centrifuging the blood of
5-week-old SCID mice at 700 rpm. The pellet was re-
suspended in saline at a ratio of 1:4. The test samples as-
synthesized iron oxide nanoparticles, hydrophilic iron
oxide nanoparticles, and BSA-conjugated, hydrophilic iron
oxide nanoparticles each of ferric ion concentration
0.5 mg mL-1 were added to the erythrocytes, and the
samples were incubated at 37 C for 2 h. Distilled water,
which leads to 100 % lysis, was used as the positive control
as it causes complete haemolysis due to osmosis. 0.1 M
NaCl was used as negative control, as it is isotonic with the
intracellular solute concentration. Haemolysis of erythro-
cytes is due to the oxidative stress caused by the test
samples on the erythrocytes. The stress ruptures the cell
membrane of the erythrocytes and hence the haemoglobin
(Hb) leaks out into the solution. The absorbance of the
leaked haemoglobin was measured at 540 nm by UV–Vis
spectrophotometer (UV–Vis, Shimadzu UV-1601). %
Haemolysis can be calculated using the formula:
%Haemolysis ¼ ½At  An=Ac  An  100;
where At is the absorbance of the test sample at 540 nm, An
is the absorbance of the negative control (0.1 M NaCl) at
540 nm and Ac is the absorbance of the positive control
(distilled water) at 540 nm.
The haemolytic index was also calculated according to
ASTM F756-00 standards, according to which, 0–2 % is
non-haemolytic; 2–5 % is mildly haemolytic and[5 % is
haemolytic [54].
2.3.2 Cell Viability Studies
The cell viability assay was performed on healthy Baby
Hamster Kidney (BHK) cells (ATCC) in order to
compare the biocompatibility of the BSA-conjugated
FIONs and hydrophilic FIONs without BSA. Cell
Counting Kit-8 (CCK-8) was used to perform the cell
viability studies.
Briefly, 100 lL of cell suspension was dispensed into
a 96-well plate and pre-incubated at optimum condi-
tions. To the well, 10 lL of BSA-APTMS-FIONs and
10 lL of APTMS-FIONs of final ferric ion concentra-
tion of 12.5, 25, 50, and 100 lg mL-1 were added. The
plate was co-incubated for 24 h. CCK-8 solution of
10 lL was added and further incubated for 4 h. The











Fig. 1 Schematic representation of (a) physical adsorption of BSA to
CTAB; (b) strong covalent amide bond formation between BSA and
APTMS
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2.4 Enhancement of Heating Efficiency
The magnetic hyperthermia studies to calculate the Specific
Absorption Rate (SAR) were carried out by placing the
sample inside a copper coil generating an external AC
magnetic field. The temperature raise of the sample with
respect to the time of exposure of the sample to an AC
magnetic field at an amplitude of 32.4 kA m-1, frequency
of 360 kHz and a magnetic field of 600 Oe was investi-
gated. SAR is expressed as the heat released by the mag-
netic iron oxide nanoparticles under a magnetic field. The
SAR value is calculated from the formula:




where Cwat is the specific heat of the medium (distilled
water), 4.18 J (g C)-1, DT/Dt is the the initial slope of the
time-dependent temperature curve and CFe is the concen-
tration of ferric ions in the medium, 0.1 mg mL-1. The
concentration of ferric ions in the samples was determined
using ICP-OES analysis (Perkin-Elmer Dual view Optima
5300 DV ICPOES system).
3 Results and Discussion
3.1 Characterization of the As-Synthesized Iron
Oxide Nanoparticles
Two different sizes of iron oxide nanoparticles were syn-
thesized by thermal decomposition method. The size was
confirmed by the TEM micrographs from Fig. 2a-i, a-ii.
Previous studies have shown that magnetite of 30 nm is
ferrimagnetic in nature [55–57]. The XRD plots from
Fig. 2b show that the particles are single crystalline and are
free of impurities. The size of the iron oxide nanoparticles
was also confirmed from the XRD data, using the
Scherrer’s formula. The diffraction peaks can be indexed as
cubic spinel Fe3O4 (JCPDS no.19-0629), corresponding to
(220), (311), (400), (422), (511), and (440). The peaks
became sharper as the particle size was increased. The
magnetization properties of the as-synthesized iron oxide
nanoparticles are shown in Fig. 3. The saturation magne-
tization (Ms) value of the as-synthesized 10 nm iron oxide
nanoparticles and 30 nm iron oxide nanoparticles measured
by VSM is 45 and 87 emu g-1 respectively, as shown in
Fig. 3a. The inset in Fig. 3a shows the coercivity exhibited
by FIONs. SQUID magnetometer was used to further
characterize ferrimagnetic behaviour of FIONs as shown in
Fig. 3b, c. The temperature-dependent field cooling (FC)
and zero-field cooling (ZFC) magnetization were measured
for the FIONs. The Verwey transition temperature (Tv) is
the reflection point of the characteristic magnetization
jump and is deduced from a ZFC plot derivative as shown
in Fig. 3b. The Tv of the as-synthesized 30 nm FIONs is
around 115 K, which is very close to the characteristic Tv
of 120 K for magnetite as reported extensively [58, 59].
The minor shift is commonly observed in magnetite
(Fe3O4) nanoparticles. The magnetization hysteresis loops
at different temperatures are shown in Fig. 3c. As observed
from the loops, the coercitivity increases as the temperature
decreases. All our magnetization studies show the charac-
teristic ferrimagnetic behaviour of 30 nm FIONs. The
higher magnetic saturation of FIONs makes it preferred
candidate for magnetic hyperthermia application.
3.2 Surface Modification of Iron Oxide
Nanoparticles
3.2.1 Conversion to Hydrophilic Phase
Figure 4a, b shows the average hydrodynamic radius of the
CTAB-SPIONs to be 20 nm and CTAB-FIONs to be























Fig. 2 Characterization of as-synthesized iron oxide nanoparticles a TEM images of (i) 10 nm SPIONs and (ii) 30 nm FIONs. b XRD plots of
SPIONs and FIONs
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APTMS-SPIONs is 15 nm and APTMS-FIONs is 50 nm as
shown in Fig. 4c, d, respectively. It was observed from the
inset images in Fig. 4b that CTAB forms a very thin
additional layer over the FIONs and CTAB-FIONs are
stable in the aqueous phase. It is also evident from the DLS
graphs that APTMS-coated iron oxide nanoparticles are
smaller in size than CTAB-coated iron oxide nanoparticles,
as APTMS forms a thin layer of ligand exchange around
the iron oxide nanoparticles. Figure 5 shows the hydrody-
namic radius of the surface modified iron oxide nanopar-
ticles as a function of time. The iron oxide nanoparticles
were quite stable over a period of 30 days. The average
hydrodynamic size of surfaced modified SPIONs and
FIONs is found to be 17.5 ± 3.5 nm and 55 ± 4 nm,
respectively.
The FTIR peak corresponding to 592 cm-1 in both the
FTIR plots is related to the Fe–O group and thus confirms
the existence of Fe3O4. The FTIR plot in Fig. 6a confirms
that the CTAB was coated over the iron oxide nanoparti-
cles. The peaks corresponding to 2900 cm-1 is due to C–H
stretching and 1440 cm-1 is due to the scissoring vibration
of methylene and asymmetric bending mode of the head
[N(CH3)3] methyl group [60].
For the APTMS-coated iron oxide nanoparticles, the
peaks at 1700 and 1648 cm-1 are due to the stretching
vibration of C = O and stretching vibration of C = C
bonds, respectively. The peaks at 1172 and 1017 cm-1 are
due to the stretching vibration of C–O. The asymmetric
stretching vibration and scissoring bending vibration of
CH2 group are represented by peaks at 2926 and
1460 cm-1, respectively [61]. This is evident from Fig. 6b.
3.2.2 Conjugation of BSA
It is also evident from Fig. 7a-i, a-ii that there is no peak
observed in the surface modified (hydrophilic) iron oxide
nanoparticles, viz, CTAB-iron oxide nanoparticles and
APTMS-iron oxide nanoparticles. The characteristic peak
of BSA is evident at 280 nm from Fig. 6a-iii. The blue-
shift in the UV–Vis spectrum shown in Fig. 7a-iv,a-v
proves that the BSA is conjugated to the hydrophilic iron
oxide nanoparticles and not merely present in the solution.
The disturbances in the polypeptide environment within the
BSA due to conjugation of the same to the surface modified
iron oxide nanoparticles system are the reason behind the
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Fig. 3 Characterization of magnetic properties of the as-synthesized iron oxide nanoparticles a Saturation magnetization values of SPIONs and
FIONs using VSM. The inset figure shows the coercivity of FIONs. SQUID measurements showing the b Verwey transition temperature (Tv) of
115 K deduced from the ZFC plot for FIONs. c Magnetization hysteresis loops of FIONs at different temperatures
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of the BSA-conjugated samples and non-conjugated sam-
ples. The reduction in surface charge after conjugating with
BSA proves that BSA was conjugated with the surface
modified iron oxide nanoparticles, as the anionic BSA
reduces the zeta potential of the system.
Figure 8a, b shows the average hydrodynamic radius of
BSA-CTAB-SPIONs to be 40 nm and BSA-CTAB-FIONs
to be 80 nm, respectively. Figure 8c, d shows the average
hydrodynamic radius of BSA-APTMS-SPIONs is 30 nm
and BSA-APTMS-FIONs is 70 nm, respectively. From the
inset images of Fig. 8b, it is evident that the FIONs are
individually conjugated by the BSA and are well separated
so as to prevent aggregation. The stability of the BSA-
conjugated iron oxide nanoparticles was enhanced when
compared to the hydrophilic iron oxide nanoparticles
without BSA conjugation, irrespective of the method of
conjugation. This is evident from the DLS plot over a
period of 1 month in Fig. 9. Thus, the average hydrody-
namic radius of BSA-SPIONs and BSA-FIONs is around
35 ± 4 and 75 ± 4 nm, respectively. The size range is
narrower and is more stable than albumin-conjugated
SPIONS reported in previous studies [37, 62].
3.3 Improvement of Biocompatibility
3.3.1 Blood Aggregation and Haemolytic Studies
The photo in Fig. 10a–e shows the effect of test samples on
erythrocytes. Figure 10a shows aggregation of ruptured
erythrocytes due to as-synthesized iron oxide nanoparti-
cles-SPIONs and FIONs. Due to the high oxidative stress,
haemoglobin was released into the solution as the ruptured
erythrocytes settled down as debris. Figure 10b, d shows




































































Fig. 4 Average hydrodynamic radius of surface modified iron oxide nanoparticles a CTAB- SPIONs; b CTAB-FIONs; c APTMS-SPIONs;



















Fig. 5 Average hydrodynamic radius of surface modified iron oxide
nanoparticles as a function of time
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CTAB-iron oxide nanoparticles and APTMS-iron oxide
nanoparticles, respectively. Mild haemolysis was observed
in this case. Figure 10c, e shows that there was a significant
reduction in haemolysis after conjugating with BSA. There
was almost no cell debris and therefore no haemoglobin
leakage in the BSA-conjugated test samples, which implies
that cell lysis was almost nil in the same. This is the reason
for the reduced absorbance at 540 nm.
Table 1 shows the UV absorbance values at 540 nm for
all the test samples. Figure 11 graphically depicts the
general mechanism of haemolysis in both as-synthesized
and BSA-conjugated iron oxide nanoparticles.
The haemolytic studies were conducted as per the
ASTM F756-00 standards. It is evident from Fig. 12a, b
that the haemolytic index of the as-synthesized hydropho-
bic SPIONs is 57 % and that of FIONs is 78 %, both well
above the 5 % standard, showing that they are highly
haemolytic in nature. From Fig. 12a, it is evident that the
haemolytic index of CTAB-SPIONs is 28 % when
compared to 2.5 % of BSA-CTAB-SPIONs and CTAB-
FIONs is 38 % when compared to 2.2 % of BSA-CTAB-
FIONs. Figure 12b shows that the haemolytic index of
APTMS-SPIONs is 17 % and that of BSA-APTMS-
SPIONs is 1.2 %. It also shows that the haemolyic index of
APTMS-FIONs is 28 % and that of BSA-APTMS-FIONs
is 1.3 %. This shows that BSA conjugation makes the iron
oxide nanoparticles almost non-haemolytic nature, as the
haemolytic index is B2 %, irrespective of the method of
conjugation. Surface modification by APTMS is non-hae-
molytic in nature, when compared to CTAB. This may be
because the covalent bonding is stronger than physical
adsorption and hence the particles are well conjugated with
BSA. It is also observed that BSA-FIONs have biocom-
patibility similar to that of BSA-SPIONs, even though their
size is bigger. Better biocompatibility for a bigger size is an
added advantage, as FIONs have better magnetic properties
to be used in magnetic hyperthermia experiments.
3.3.2 Cell Viability Studies
Since APTMS-FIONs and BSA-APTMS-FIONs showed
reduced or nil haemolysis, respectively, we performed cell
viability studies using the same. The BSA-conjugated
APTMS-FIONs show a normalized viability range of up to
120 % (for 12.5 and 25 lg mL-1), when compared to the
normalized 100 % of APTMS-FIONs (for 12.5 and
25 lg mL-1). Previous studies also show that addition of
BSA-conjugated SPIONs without the external application
of magnetic field show no harmful effect on cell viability
[37]. It is also evident from Fig. 13 that the cell viability
decreases as the concentration of FIONs in the test sample
increases, as in 50 and 100 lg mL-1. This shows that
BSA-conjugated FIONs exhibit less or no cytotoxicity to
healthy BHK cells.
From the haemolytic studies and the cell viability
studies, it is evident that BSA conjugation improves the
biocompatibility of the iron oxide nanoparticles system.
BSA-FIONs show better results when compared BSA-
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Fig. 7 a UV–Vis spectrum for (i) CTAB-iron oxide nanoparticles,
(ii) APTMS-iron oxide nanoparticles, (iii) BSA (iv) BSA-CTAB-iron
oxide nanoparticles, (v) BSA-APTMS-iron oxide nanoparticles.
b Zetapotential values surface modified and BSA-conjugated iron
oxide nanoparticles
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SPIONs or as-synthesized particles or the hydrophilic
particles. Thus, the first requisite for an efficient magnetic
hyperthermia system is met out.
3.4 Enhancement of Heating Efficiency
The heating efficiency of the hydrophilic iron oxide
nanoparticles and BSA-conjugated iron oxide nanoparticles
were studied by the magnetic hyperthermia experiments.
The SAR value is higher for the BSA-conjugated system,
even after the effect of residual BSA was corrected from
the system. Figure 14a shows the temperature raise com-
parison of the CTAB-iron oxide nanoparticles and BSA-
CTAB-iron oxide nanoparticles. From Fig. 14b, it is evi-
dent that the SAR value of CTAB-SPIONs is 270 W g-1
and that of BSA-CTAB-SPIONs is 540 W g-1; CTAB-
FIONs are 1750 W g-1 and that of BSA-CTAB-FIONs is
2200 W g-1. Figure 14c shows the temperature raise
comparison of APTMS-iron oxide nanoparticles and BSA-


































































Fig. 8 Average hydrodynamic size of BSA-conjugated, surface modified iron oxide nanoparticles a BSA-CTAB-SPIONs, b BSA-CTAB-




















Fig. 9 Average hydrodynamic radius of BSA-conjugated, surface
modified iron oxide nanoparticles as a function of time
(a) (b) (c) (d) (e)
Fig. 10 Haemolytic effect of test samples a as-synthesized iron oxide
nanoparticles; b CTAB-iron oxide nanoparticles; c BSA-CTAB-iron
oxide nanoparticles; d APTMS-iron oxide nanoparticles; e BSA-
APTMS-iron oxide nanoparticles
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around 11 C is observed in BSA-FIONs, when compared
to the 3 C raise shown by BSA-SPIONs in 3 min. Fig-
ure 14d shows that the SAR value of APTMS-SPIONs is
480 W g-1 when compared to 520 W g-1 of BSA-
APTMS-SPIONs; APTMS-FIONs are 1700 W g-1 and
BSA-APTMS-FIONs are 2300 W g-1. It is observed that
the covalent bond method using APTMS shows slightly
better efficiency irrespective of the size of the particles due
to the strong bonding between the hydrophilic iron oxide
particles and the BSA and hence improved colloidal sta-
bility. It is evident that FIONs of 30 nm size show higher
SAR value than SPIONS of 10 nm size, due to their higher
saturation magnetization. This makes FIONs better suited
candidates for improving the SAR value of the magnetic
hyperthermia system, when compared to SPIONs.
The SAR value plots show that, irrespective of the
method of conjugation, BSA improves the heating effi-
ciency of the system. While here we report the phe-
nomenon, we are to further investigate the possible reasons
Human blood
Red blood cell
Oxidative stress due to
iron oxide nanoparticles
damage the cell membrane
BSA-iron oxide nanoparticles
are non-haemolytic
Haemoglobin is leaked out and
haemolysed cell debris settles down
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Fig. 13 The BSA-conjugated APTMS-FIONs exhibit higher per-
centage of cell viability than the non-conjugated FIONs
Table 1 Showing the absorbance of haemoglobin at 540 nm
Sample Absorbance @ 540 nm
Positive control (distilled water) 0.15
Negative control (0.1 M NaCl) 0.002
10 nm SPIONs 0.098
30 nm FIONs 0.12
CTAB-10 nm SPIONs 0.03
BSA-CTAB-10 nm SPIONs 0.0062
CTAB-30 nm FIONs 0.045
BSA-CTAB-30 nm FIONs 0.007
APTMS-10 nm SPIONs 0.04
BSA-APTMS-10 nm SPIONs 0.0083
APTMS-30 nm FIONs 0.058
BSA-APTMS-30 FIONs 0.0093
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behind this interesting phenomenon. It is stated elsewhere
that isotropic clusters of BSA are formed under AC mag-
netic field [63]. Isotropic clusters might have possibly
prevented the fibrous aggregation of iron oxide nanoparti-
cles under the AC magnetic field. In general, fibrous
aggregation increases the critical size of the nanoparticles
in a solution and hence decreases the specific heat of the
system. It is well reported that aggregation of nanoparticles
decreases the SAR value significantly [40, 64]. Prevention
of aggregation by BSA conjugation might have thus
enhanced the SAR value of the system. As reported by
Samanta et al. in similar studies with SPIONs, this phe-
nomenon could also be attributed to the increased colloidal
stability of the BSA-conjugated iron oxide nanoparticles
[37]. The BSA-conjugated iron oxide nanoparticles were
well separated and well suspended, even under applied
magnetic field, whereas the hydrophilic iron oxide
nanoparticles without BSA conjugation aggregate in the
presence of magnetic field. This interesting phenomenon of
improved heating efficiency relating to the colloidal sta-
bility imparted by the BSA to the iron oxide nanoparticles
will be studied further.
BSA conjugation over FIONs show better SAR value
than the BSA-SPIONS, due to the high saturation magne-
tization. Thus, the second requisite for an efficient mag-
netic hyperthermia system is also well established.
4 Conclusion
We have studied the biocompatibility and heating charac-
teristics of both BSA-SPIONS and BSA-FIONs. The iron
oxide nanoparticles were synthesized by the preferred
thermal decomposition method using organic solvents.
BSA conjugation was done by both physical adsorption and
strong covalent amide bond formation.
The haemolytic studies and cell viability studies dis-
cussed in the paper confirm that the biocompatibility of the
iron oxide nanoparticles increased after BSA conjugation.
Particularly BSA-FIONs show better biocompatibility than
that of BSA-SPIONs. The improved SAR value of the
BSA-conjugated iron oxide nanoparticles system is due to
the enhanced colloidal stability and prevention of aggre-
gation. Though the study of efficiency of the surface
CTAB 10 nm SPIONs
BSA-CTAB 10 nm SPIONs
CTAB 30 nm FIONs







































Fig. 14 Heating characteristics a temperature raise comparison between BSA-CTAB-iron oxide nanoparticles and CTAB-iron oxide
nanoparticles; b SAR value comparison between BSA-CTAB-iron oxide nanoparticles and CTAB-iron oxide nanoparticles; c Temperature raise
comparison between BSA-APTMS-iron oxide nanoparticles and APTMS-iron oxide nanoparticles; d SAR value comparison between BSA-
APTMS-iron oxide nanoparticles and APTMS-iron oxide nanoparticle
90 Nano-Micro Lett. (2016) 8(1):80–93
123
modifying agents used is beyond the scope of this paper,
we still report that BSA conjugation by covalent bonding
using APTMS has better colloidal stability and hence better
biocompatibility and heating efficiency, as BSA-APTMS-
FIONs show better results than that of BSA-CTAB-FIONs.
Also the higher magnetic saturation of FIONs leads to
higher SAR value and hence better heating efficiency than
SPIONs.
We thus conclude that the two key challenges of a very
good magnetic hyperthermia system-improved biocom-
patibility and heating enhancement were addressed through
the fabrication of BSA-FIONs. To the best of our knowl-
edge, there are no previous systematic studies on the same.
A multivariate therapeutic strategy combining magnetic
hyperthermia and chemotherapy using targeted, ligand-
conjugated FIONs, could be an extension of our work.
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